Brief: Option Therapeutics Files For IPO Of 2.3 Million Shares Of Common Stock - SEC Filing
26/01/2026 11:06
Jan 26 (Reuters) - BioVie Inc BIVI.O: OPTION THERAPEUTICS INC - FILES FOR IPO OF 2.3 MILLION SHARES OF COMMON STOCK - SEC FILING OPTION THERAPEUTICS INC - IPO PRICE EXPECTED BETWEEN $10.00 AND $12.00 PER SHARE - SEC FILING OPTION THERAPEUTICS INC - INTENDS TO LIST ON NYSE AMERICAN UNDER SYMBOL "OPTN" - SEC FILING OPTION THERAPEUTICS INC SAYS THINKEQUITY IS THE UNDERWRITER TO IPO Source text: [ID:n0001520138-26-000041] Further company coverage: BIVI.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on BioVie
See all newsBrief: Biovie Files To Offer Up To $300 Million In Securities - SEC Filing
Brief: Option Therapeutics Files For IPO Of 2.3 Million Shares Of Common Stock - SEC Filing
Brief: Biovie Completes Enrollment In Phase 2 Sunrise-Pd Trial In Early Parkinson’S Disease
Brief: Biovie Announces Pricing Of $12 Million Public Offering
Brief: Biovie Initiates Sunrise-Pd Clinical Trial Assessing Bezisterim In Early Parkinson’S Disease With First Patient Enrolled